Dow Down1.29% Nasdaq Down3.25%

United Therapeutics Corporation (UTHR)

-NasdaqGS
118.45 Down 4.30(3.50%) Feb 5, 4:00PM EST
|After Hours : 118.45 0.00 (0.00%) Feb 5, 4:57PM EST
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingSep 30, 2015Jun 30, 2015Mar 31, 2015Dec 31, 2014
Total Revenue 386,221   347,161   327,504   346,363  
Cost of Revenue6,891  16,058  20,778  15,770  
Gross Profit 379,330   331,103   306,726   330,593  
Operating Expenses
Research Development9,527  49,411  110,212  71,482  
Selling General and Administrative(17,276)109,987  211,340  80,534  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 387,079   171,705   (14,826) 178,577  
Income from Continuing Operations
Total Other Income/Expenses Net350,618  (2,075)93  (286)
Earnings Before Interest And Taxes737,697  169,630  (14,733)178,291  
Interest Expense834  1,296  2,059  3,527  
Income Before Tax736,863  168,334  (16,792)174,764  
Income Tax Expense272,438  69,123  (151)58,829  
Minority Interest -   -   -   -  
Net Income From Continuing Ops464,425  99,211  (16,641)115,935  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 464,425   99,211   (16,641) 115,935  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 464,425   99,211   (16,641) 115,935  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.